Swiss National Bank

Swiss National Bank Portfolio holdings

AUM $167B
 

The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.

This Quarter Return
+9.31%
1 Year Return
+24.69%
3 Year Return
+110.21%
5 Year Return
+190.84%
10 Year Return
+479.95%
AUM
$162B
AUM Growth
+$162B
Cap. Flow
+$1.24B
Cap. Flow %
0.77%
Top 10 Hldgs %
24.82%
Holding
2,687
New
205
Increased
910
Reduced
1,480
Closed
45

Sector Composition

1 Technology 27.15%
2 Healthcare 14.17%
3 Consumer Discretionary 13.28%
4 Communication Services 11.57%
5 Industrials 8.99%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ADVM icon
2626
Adverum Biotechnologies
ADVM
$64.6M
$468K ﹤0.01% 133,700
KALA icon
2627
KALA BIO
KALA
$78.8M
$467K ﹤0.01% 88,200 +12,400 +16% +$65.7K
RMNI icon
2628
Rimini Street
RMNI
$401M
$461K ﹤0.01% +74,900 New +$461K
BCEL
2629
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$453K ﹤0.01% 53,200 -8,500 -14% -$72.4K
DGICA icon
2630
Donegal Group Class A
DGICA
$653M
$443K ﹤0.01% 30,400
TRMD icon
2631
TORM
TRMD
$2.13B
$440K ﹤0.01% 49,679 -18,206 -27% -$161K
BOLT icon
2632
Bolt Biotherapeutics
BOLT
$9.85M
$433K ﹤0.01% +28,000 New +$433K
ATER icon
2633
Aterian
ATER
$9.65M
$429K ﹤0.01% +29,300 New +$429K
VLGEA icon
2634
Village Super Market
VLGEA
$535M
$426K ﹤0.01% 18,100 -1,500 -8% -$35.3K
LBC
2635
DELISTED
Luther Burbank Corporation Common Stock
LBC
$421K ﹤0.01% 35,500
HMTV
2636
DELISTED
Hemisphere Media Group, Inc.
HMTV
$421K ﹤0.01% 35,700 -2,700 -7% -$31.8K
VTOL icon
2637
Bristow Group
VTOL
$1.11B
$420K ﹤0.01% 16,400 -700 -4% -$17.9K
AKUS
2638
DELISTED
Akouos, Inc. Common Stock
AKUS
$333K ﹤0.01% 26,500 -4,900 -16% -$61.6K
CRD.A icon
2639
Crawford & Co Class A
CRD.A
$538M
$309K ﹤0.01% 34,038 -4,200 -11% -$38.1K
AGRO icon
2640
Adecoagro
AGRO
$847M
$259K ﹤0.01% +25,800 New +$259K
BMTX
2641
DELISTED
BM Technologies, Inc.
BMTX
$130K ﹤0.01% 10,449
CMD
2642
DELISTED
Cantel Medical Corporation
CMD
-86,950 Closed -$6.94M
AC icon
2643
Associated Capital Group
AC
$699M
-7,300 Closed -$262K
APRE icon
2644
Aprea Therapeutics
APRE
$9.12M
-21,200 Closed -$108K
ASMB icon
2645
Assembly Biosciences
ASMB
$190M
-70,500 Closed -$324K
BABA icon
2646
Alibaba
BABA
$322B
-4,709,969 Closed -$1.07B
CIA icon
2647
Citizens
CIA
$266M
-112,700 Closed -$653K
CODX icon
2648
Co-Diagnostics
CODX
$12.7M
-57,100 Closed -$545K
FUTU icon
2649
Futu Holdings
FUTU
$25.8B
-77,400 Closed -$12.3M
ITOS icon
2650
iTeos Therapeutics
ITOS
$449M
-27,700 Closed -$947K